γδ17T Cells Hinder Mandibular Bone Defect Healing
By R. Naamneh, F.L. Shoukair, M. Gera, Y. Jaber, S. Yacoub, Y. Netanely, Y. Saba, K. Zubeidat, A. Wilensky, I. Prinz, N. Casap, A.H. Hovav
Originally at journals.sagepub.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Preclinical findings show that γδ17T cells (a subset of T-cells) actively impair mandibular bone defect healing, suggesting that immune modulation may become a new target for improving alveolar ridge preservation and implant success in oral surgery.
Key points
- Mandibular bone healing differs from long-bone healing due to its flat-bone structure and unique immune microenvironment.
- γδ17T cells release IL-17, which disrupts the coordinated immune-skeletal response needed for proper mandibular fracture or defect repair.
- Study published in Journal of Dental Research (July 2026, Vol 105, Issue 8, pp. 1049-1057) provides mechanistic data that could inform future biologic therapies or drug targets.
- Oral surgeons, periodontists, and implantologists should monitor follow-up translational work on IL-17 pathway inhibitors for potential adjunct use in bone-grafting procedures.
Who should care
Read the original on Journal of Dental Research (JDR)
Full reporting and any paywall content live on journals.sagepub.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Florida dental office remains closed amid patient death investigation
- ·Clinical
Association of toothbrushing, dental flossing, and interdental brushing with stroke risk
- ·Clinical
Clinical accuracy and short-term outcomes of intraoral photogrammetry for complete-arch implant rehabilitation: A retrospective multicentre study on 35 patients
- ·Clinical
Site‐Resolved Gingival Microcirculation and Colour Features in Health and Early Inflammation